TriSalus Life Sciences, Inc. financial data

Symbol
TLSI, TLSIW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
6272 West 91 St Avenue, Westminster, CO
State of incorporation
DE
Fiscal year end
December 31
Former names
MedTech Acquisition Corp (to 8/10/2023), MedTech Acquisition Corporation (to 10/29/2020)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 181 % +352%
Quick Ratio 20.9 %
Debt-to-equity -243 % -2182%
Return On Equity 284 % +858%
Return On Assets -198 % -187%
Operating Margin -212 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.3M shares
Common Stock, Shares, Outstanding 27.2M shares +3.2%
Common Stock, Value, Issued 2K USD
Weighted Average Number of Shares Outstanding, Basic 23.9M shares +5256%
Weighted Average Number of Shares Outstanding, Diluted 23.9M shares +5256%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 24.7M USD +59.7%
Research and Development Expense 27.5M USD -32.2%
Selling and Marketing Expense 23M USD +71.9%
General and Administrative Expense 23.6M USD +18.4%
Operating Income (Loss) -52.5M USD +8.03%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -54.3M USD +27.2%
Income Tax Expense (Benefit) 11K USD -46.2%
Net Income (Loss) Attributable to Parent -54.3M USD -2.78%
Earnings Per Share, Basic 28.9 USD/shares +99.4%
Earnings Per Share, Diluted 28.9 USD/shares +99.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16.5M USD +15751%
Accounts Receivable, after Allowance for Credit Loss, Current 4.71M USD
Inventory, Net 3.44M USD
Assets, Current 27.9M USD +17206%
Property, Plant and Equipment, Net 1.83M USD
Operating Lease, Right-of-Use Asset 1.12M USD
Other Assets, Noncurrent 424K USD
Assets 32.4M USD +165%
Accrued Liabilities, Current 9.41M USD
Liabilities, Current 12M USD +98.9%
Operating Lease, Liability, Noncurrent 1.16M USD
Liabilities 56.6M USD +270%
Retained Earnings (Accumulated Deficit) -266M USD -1659%
Stockholders' Equity Attributable to Parent -24.1M USD +87.8%
Liabilities and Equity 32.4M USD +165%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.9M USD -3.47%
Net Cash Provided by (Used in) Financing Activities 3.13M USD -60.6%
Net Cash Provided by (Used in) Investing Activities -66K USD +10.8%
Common Stock, Shares Authorized 400M shares
Common Stock, Shares, Issued 27.2M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.81M USD -195%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16.8M USD +305%
Deferred Tax Assets, Valuation Allowance 51.3M USD +33.8%
Deferred Tax Assets, Gross 51.8M USD +34.7%
Operating Lease, Liability 1.43M USD
Payments to Acquire Property, Plant, and Equipment 66K USD +843%
Lessee, Operating Lease, Liability, to be Paid 1.9M USD
Operating Lease, Liability, Current 275K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 205K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 380K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 470K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 213K USD
Deferred Tax Assets, Operating Loss Carryforwards 37.3M USD +22.7%
Preferred Stock, Shares Issued 4.02M shares
Preferred Stock, Shares Authorized 10M shares +900%
Lessee, Operating Lease, Liability, to be Paid, Year Four 219K USD
Additional Paid in Capital 242M USD
Preferred Stock, Shares Outstanding 4.02M shares
Amortization of Intangible Assets 13K USD -40.9%
Interest Expense 887K USD +21825%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%